Jump to: navigation, search

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

WikiDoc Resources for N-Nitroso-N-methylurea


Most recent articles on N-Nitroso-N-methylurea

Most cited articles on N-Nitroso-N-methylurea

Review articles on N-Nitroso-N-methylurea

Articles on N-Nitroso-N-methylurea in N Eng J Med, Lancet, BMJ


Powerpoint slides on N-Nitroso-N-methylurea

Images of N-Nitroso-N-methylurea

Photos of N-Nitroso-N-methylurea

Podcasts & MP3s on N-Nitroso-N-methylurea

Videos on N-Nitroso-N-methylurea

Evidence Based Medicine

Cochrane Collaboration on N-Nitroso-N-methylurea

Bandolier on N-Nitroso-N-methylurea

TRIP on N-Nitroso-N-methylurea

Clinical Trials

Ongoing Trials on N-Nitroso-N-methylurea at Clinical Trials.gov

Trial results on N-Nitroso-N-methylurea

Clinical Trials on N-Nitroso-N-methylurea at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on N-Nitroso-N-methylurea

NICE Guidance on N-Nitroso-N-methylurea


FDA on N-Nitroso-N-methylurea

CDC on N-Nitroso-N-methylurea


Books on N-Nitroso-N-methylurea


N-Nitroso-N-methylurea in the news

Be alerted to news on N-Nitroso-N-methylurea

News trends on N-Nitroso-N-methylurea


Blogs on N-Nitroso-N-methylurea


Definitions of N-Nitroso-N-methylurea

Patient Resources / Community

Patient resources on N-Nitroso-N-methylurea

Discussion groups on N-Nitroso-N-methylurea

Patient Handouts on N-Nitroso-N-methylurea

Directions to Hospitals Treating N-Nitroso-N-methylurea

Risk calculators and risk factors for N-Nitroso-N-methylurea

Healthcare Provider Resources

Symptoms of N-Nitroso-N-methylurea

Causes & Risk Factors for N-Nitroso-N-methylurea

Diagnostic studies for N-Nitroso-N-methylurea

Treatment of N-Nitroso-N-methylurea

Continuing Medical Education (CME)

CME Programs on N-Nitroso-N-methylurea


N-Nitroso-N-methylurea en Espanol

N-Nitroso-N-methylurea en Francais


N-Nitroso-N-methylurea in the Marketplace

Patents on N-Nitroso-N-methylurea

Experimental / Informatics

List of terms related to N-Nitroso-N-methylurea

Template:Chembox ECNumberTemplate:Chembox E number
Skeletal formula of N-nitroso-N-methylurea
Template:Chembox image sbs cell
IUPAC name
3D model (JSmol)
Abbreviations NMU[citation needed]
Beilstein Reference 1756040
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
MeSH Methylnitrosourea
Molar mass 103.08 g·mol−1
log P −0.302
Acidity (pKa) 12.365
Basicity (pKb) 1.632
Related compounds
Related {{{label}}} {{{value}}}
Related compounds
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references


N-Nitroso-N-methylurea (NMU) is a highly reliable carcinogen, mutagen, and teratogen. NMU is an alkylating agent, and exhibits its toxicity by transferring its methyl group to nucleobases in nucleic acids, which can lead to AT:GC transition mutations.

NMU is the traditional precursor in the synthesis of diazomethane. However, since it is unstable at temperatures beyond 20 °C and shock-sensitive to a degree, for this purpose it has become obsolete and replaced by other (N-methyl)nitrosamides. Most chemical supply houses have stopped carrying it.

Acute exposure to NMU in humans can result in skin and eye irritation, headache, nausea, and vomiting.[2] NMU is reasonably anticipated to be a human carcinogen based on sufficient evidence of carcinogenicity in experimental animals (IARC 1972, 1978, 1987).[3] Various cancers induced in animal models include: squamous cell carcinomas of the forestomach, sarcomas and gliomas of the brain, adenocarcinomas of the pancreas, leukemia, and lymphomas.[3] However, the actual potential for human exposure is quite limited, as the chemical is not produced or used in large quantities [3]

NMU is teratogenic and embryotoxic, resulting in craniofacial (cleft palate) and skeletal defects, increased fetal resorption, and fetal growth retardation.[4][5][6] Exposure to NMU during pre-implantation, post-implantation, organogenesis, or by paternal exposure can result in these effects.


  1. "Methylnitrosourea - Compound Summary". PubChem Compound. USA: National Center for Biotechnology Information. 26 March 2005. Identification. Retrieved 1 May 2012.
  2. Hazardous Substance Fact Sheet for NMU New Jersey Department of Health and Senior Services
  3. 3.0 3.1 3.2 NMU Substance Profile NTP, Report on Carcinogens, Eleventh Edition
  4. Wada, A., et al. (1994). Induction of Congenital Malformations in Mice by Paternal Methylnitrosourea Treatment. Congenital Anomalies 34:65-70.
  5. Nagao, T., et al. (1991). Induction of Fetal Malformations After Treatment of Mouse Embryos with Methylnitrosourea at the Preimplantation Stages. Teratogenesis, Carcinogenesis, and Mutagenesis 11:1-10.
  6. Faustman, E., et al. (1989). In Vitro Developmental Toxicity of Five Direct-Acting Alkylating Agents in Rodent Embryos: Structure-Activity Patterns. Teratology 40:199-210.